TNFSF10 and cancer: However, despite encouraging results observed in an experimental setting, the efficiency of this approach in patients remained only limited [13], most likely because cancer cells may be resistant to TRAIL per se or rapidly acquire inducible resistance upon TRAIL treatment [8, 14].